Literature DB >> 21250997

Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism.

Abha Chauhan1, Feng Gu, Musthafa M Essa, Jerzy Wegiel, Kulbir Kaur, William Ted Brown, Ved Chauhan.   

Abstract

Mitochondria play important roles in generation of free radicals, ATP formation, and in apoptosis. We studied the levels of mitochondrial electron transport chain (ETC) complexes, that is, complexes I, II, III, IV, and V, in brain tissue samples from the cerebellum and the frontal, parietal, occipital, and temporal cortices of subjects with autism and age-matched control subjects. The subjects were divided into two groups according to their ages: Group A (children, ages 4-10 years) and Group B (adults, ages 14-39 years). In Group A, we observed significantly lower levels of complexes III and V in the cerebellum (p<0.05), of complex I in the frontal cortex (p<0.05), and of complexes II (p<0.01), III (p<0.01), and V (p<0.05) in the temporal cortex of children with autism as compared to age-matched control subjects, while none of the five ETC complexes was affected in the parietal and occipital cortices in subjects with autism. In the cerebellum and temporal cortex, no overlap was observed in the levels of these ETC complexes between subjects with autism and control subjects. In the frontal cortex of Group A, a lower level of ETC complexes was observed in a subset of autism cases, that is, 60% (3/5) for complexes I, II, and V, and 40% (2/5) for complexes III and IV. A striking observation was that the levels of ETC complexes were similar in adult subjects with autism and control subjects (Group B). A significant increase in the levels of lipid hydroperoxides, an oxidative stress marker, was also observed in the cerebellum and temporal cortex in the children with autism. These results suggest that the expression of ETC complexes is decreased in the cerebellum and the frontal and temporal regions of the brain in children with autism, which may lead to abnormal energy metabolism and oxidative stress. The deficits observed in the levels of ETC complexes in children with autism may readjust to normal levels by adulthood.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21250997      PMCID: PMC4839269          DOI: 10.1111/j.1471-4159.2011.07189.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  79 in total

Review 1.  Supramolecular structure of the mitochondrial oxidative phosphorylation system.

Authors:  Egbert J Boekema; Hans-Peter Braun
Journal:  J Biol Chem       Date:  2006-11-13       Impact factor: 5.157

2.  Brain volume in autism.

Authors:  A Y Hardan; N J Minshew; M Mallikarjuhn; M S Keshavan
Journal:  J Child Neurol       Date:  2001-06       Impact factor: 1.987

3.  Serum serotonin, lactate and pyruvate levels in infantile autistic children.

Authors:  A László; E Horváth; E Eck; M Fekete
Journal:  Clin Chim Acta       Date:  1994-09       Impact factor: 3.786

Review 4.  The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology.

Authors:  G Lenaz
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

5.  Course of behavioral change in autism: a retrospective study of high-IQ adolescents and adults.

Authors:  J Piven; J Harper; P Palmer; S Arndt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 8.829

Review 6.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

7.  Mitochondrial dysfunction in autistic patients with 15q inverted duplication.

Authors:  Pauline A Filipek; Jenifer Juranek; Moyra Smith; Lee Z Mays; Erica R Ramos; Maureen Bocian; Diane Masser-Frye; Tracy M Laulhere; Charlotte Modahl; M Anne Spence; J Jay Gargus
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

8.  Histoanatomic observations of the brain in early infantile autism.

Authors:  M Bauman; T L Kemper
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

Review 9.  Neurometabolic disorders and dysfunction in autism spectrum disorders.

Authors:  Nassim Zecavati; Sarah J Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

10.  Use of the childhood autism rating scale with autistic adolescents and adults.

Authors:  G B Mesibov; E Schopler; B Schaffer; N Michal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-07       Impact factor: 8.829

View more
  78 in total

1.  Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy.

Authors:  Daniel A Rossignol; Richard E Frye
Journal:  J Autism Dev Disord       Date:  2012-04

2.  The neurogenic basic helix-loop-helix transcription factor NeuroD6 enhances mitochondrial biogenesis and bioenergetics to confer tolerance of neuronal PC12-NeuroD6 cells to the mitochondrial stressor rotenone.

Authors:  Kristin Kathleen Baxter; Martine Uittenbogaard; Anne Chiaramello
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

3.  A mitochondrial bioenergetic etiology of disease.

Authors:  Douglas C Wallace
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

Review 4.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

5.  Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.

Authors:  Suzanne Goh; Zhengchao Dong; Yudong Zhang; Salvatore DiMauro; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

6.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

Review 7.  Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight.

Authors:  Fares Zeidán-Chuliá; José Luiz Rybarczyk-Filho; Alla B Salmina; Ben-Hur Neves de Oliveira; Mami Noda; José Cláudio F Moreira
Journal:  Neuromolecular Med       Date:  2013-03-02       Impact factor: 3.843

Review 8.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

Review 9.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

10.  Mitochondrial abnormalities in temporal lobe of autistic brain.

Authors:  Guomei Tang; Puri Gutierrez Rios; Sheng-Han Kuo; Hasan Orhan Akman; Gorazd Rosoklija; Kurenai Tanji; Andrew Dwork; Eric A Schon; Salvatore Dimauro; James Goldman; David Sulzer
Journal:  Neurobiol Dis       Date:  2013-01-17       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.